Toho Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending September 30, 2021 and Fiscal Year Ending March 31, 2022
August 06, 2021 at 11:45 am IST
Share
Toho Holdings Co., Ltd. provided consolidated earnings guidance for the period ending September 30, 2021 and fiscal year ending March 31, 2022. For the period ending September 30, 2021, the company expects net sales to be JPY 596,000 million. Operating profit to be JPY 1,700 million. Profit attributable to owners of parent to be JPY 3,100 million. Basic earnings per share to be JPY 43.96.
For the year, the company expects net sales to be JPY 1,192,000 million. Operating profit to be JPY 6,400 million. Profit attributable to owners of parent to be JPY 7,400 million. Basic earnings per share to be JPY 104.92.
Toho Holdings Co Ltd is a Japan-based company mainly engaged in the pharmaceutical wholesale business. The Company operates through five business segments. The Pharmaceutical Wholesale segment purchases pharmaceuticals and medical-related products from pharmaceutical manufacturers and sells them to hospitals, clinics and dispensing pharmacies. It is also engaged in the provision of data processing system and rental of real estate. The Dispensing Pharmacy segment is engaged in the management of insurance dispensing pharmacies and dispensing pharmacies. The Pharmaceutical Manufacture and Sale segment is engaged in the manufacture and sale of generic drugs and contract manufacturing of injectable drugs. The Clinical Trial Facility Support segment is engaged in the provision of support for clinical trial facilities. The Information Equipment Sales segment is engaged in the planning and sale of information processing equipment.
TOHO HOLDINGS CO., LTD. 
